Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.85 | ||
| Change(%) | ![]() | +0.04 | |
| Volume | 651943 | ||
| 3:26 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon Commences Phase II Trial of PEG-SN38
-- Conference Call With Principal Investigators to be Held Tomorrow--
Enzon Discontinues its Plan to Spin-off its Biotechnology Business
Enzon Reports Third Quarter 2007 Results
Enzon Reports Significant Progress on the Reduction of Its Debt

Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
Enzon Concludes Tender Offer for a Portion of Its Debt
Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
-- Improved version to expand global potential --
Enzon Pharmaceuticals to Add New Independent Director to Board
